Dow Down 0.12% Nasdaq Up 0.20%

Synageva BioPharma Corp. (GEVA)

-NasdaqGS
73.19 Up 2.97(4.23%) 2:09PM EDT - Nasdaq Real Time Price
Prev Close:70.22
Open:70.19
Bid:72.80 x 100
Ask:73.02 x 100
1y Target Est:111.50
Beta:0.59
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:69.52 - 73.25
52wk Range:44.54 - 119.42
Volume:87,070
Avg Vol (3m):277,150
Market Cap:2.43B
P/E (ttm):N/A
EPS (ttm):-4.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GEVA

Comparison

Symbol% ChgMkt Cap
GEVAUp 4.23%2.43B
GILDUp 2.27%158.11B
MRKUp 0.60%170.78B
PFEUp 0.49%183.63B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):265.49
Ex-Dividend Date:30-Dec-08

Analysts

Annual EPS Est (Dec-14) :-6.16
Quarterly EPS Est (Sep-14) :-1.65
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synageva BioPharma Corp. operates as a biopharmaceutical company in the United States. It focuses on the discovery, development, and commercialization of therapeutic products for patients with rare diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback